• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

May 18, 2020
Company Drug/Device Medical Condition Status
COVID-19 Trials and Actions
Enlivex Therapeutics Allocetra COVID-19 initiation of phase 2 trial
Bellerophon Therapeutics INOpulse inhaled nitric oxide COVID-19 IND approved by the FDA
Moderna Therapeutics mRNA-1273 COVID-19 vaccine IND approved by the FDA; Fast Track designation granted by the FDA
Pluristem PLX cells severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome (ARDS) IND approved by the FDA
Redhill Biosciences opaganib (Yeliva, ABC294640) moderate-to-severe SARS-CoV-2 infection IND approved by the FDA
Abbott SARS-CoV-2 IgG lab-based serology blood test COVID-19 antibody detection test Emergency Use Authorization (EUA) granted by the FDA
Applied DNA Sciences Linea COVID-19 RT-PCR test SARS-CoV-2 detection EUA granted by the FDA
Quidel the Sofia 2 SARS Antigen FIA rapid detection of SARS-Cov-2 antigens EUA granted by the FDA
Rutgers Clinical Genomics Laboratory Spectrum Solutions LLC SDNA-1000 Saliva Collection Device COVID-19 antibody detection test EUA granted by the FDA
Sherlock Biosciences Sherlock CRISPR SARS-CoV-2 kit rapid detection of SARS-Cov-2 antigens EUA granted by the FDA
Zymo Research Quick SARS-CoV-2 rRT-PCR Kit rapid detection of SARS-Cov-2 antigens EUA granted by the FDA
Other Trials and Actions
Ocular Therapeutix OTX-CSI (cyclosporine intracanalicular insert) dry eye disease dosing of first patient in phase 1 trial
I-Mab Biopharma TJ004309 advanced solid tumors dosing of first patients in phase 1/2 trial
Rubius Therapeutics RTX-240 relapsed/refractory or locally advanced solid tumors dosing of first patients in phase 1/2 trial
Strongbridge Biopharma Recorlev (levoketoconazole) endogenous Cushing’s syndrome completion of patient enrollment in phase 3 trial
AgenTus Therapeutics agenT-797 cancer IND approved by the FDA
Histogen HST 001 androgenic alopecia in men IND approved by the FDA
SciMount Pharmatech SMP-100 Irritable Bowel Syndrome with diarrhea IND approved by the FDA
Amgen

Cytokinetics
omecamtiv mecarbil chronic heart failure with reduced ejection fraction Fast Track designation granted by the FDA
AstraZeneca

Daichi Sankyo
Enhertu (fam-trastuzumab deruxtecan-nxki) patients with HER2 positive unresectable or metastatic gastric cancer who have received two or more prior regimens including trastuzumab Breakthrough Therapy designation granted by the FDA
CRISPR Therapeutics

Vertex Pharmaceuticals
CTX001 severe sickle cell disease and transfusion-dependent beta thalassemia Regenerative Medicine Advanced Therapy designation granted by the FDA
Eli Lilly Retevmo (selpercatinib) adults with metastatic RET fusion-positive non-small cell lung cancer and adult and pediatric patients <12 years of age with advanced or metastatic RET-mutant medullary thyroid cancer or advanced or metastatic RET fusion-positive thyroid cancer approved by the FDA
AstraZeneca

Merck
Lynparza (olaparib) in combination with bevacizumab first-line maintenance treatment for HRD-positive advanced ovarian cancer approved by the FDA

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing